Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06846541
What this trial is testing

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis (PsO)Psoriasis+2 more
Alumis Inc 1,680
Large-scale testing (Phase 3)Study completedNCT05174598
What this trial is testing

A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis

Who this might be right for
Mild to Moderate Plaque Psoriasis
Cadila Pharnmaceuticals 278
Large-scale testing (Phase 3)Study completedNCT06488664
What this trial is testing

An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AO GENERIUM 422
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Testing effectiveness (Phase 2)Study completedNCT01071252
What this trial is testing

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 125
Testing effectiveness (Phase 2)Study completedNCT00645905
What this trial is testing

Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 148
Early research (Phase 1)Study completedNCT02607774
What this trial is testing

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT05547490
What this trial is testing

Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 3,506
Post-approval studies (Phase 4)Study completedNCT00881868
What this trial is testing

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Scalp Psoriasis
Galderma R&D 81
Large-scale testing (Phase 3)Study completedNCT06066125
What this trial is testing

Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 351
Post-approval studies (Phase 4)Study completedNCT03441789
What this trial is testing

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
L.H. Kircik, M.D. 28
Testing effectiveness (Phase 2)Study completedNCT06602219
What this trial is testing

LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 222
Testing effectiveness (Phase 2)Ended earlyNCT01704599
What this trial is testing

Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Wayne State University 8
Testing effectiveness (Phase 2)UnknownNCT06077331
What this trial is testing

Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 120
Large-scale testing (Phase 3)Ended earlyNCT02786732
What this trial is testing

Study to Evaluate Broadlumab vs Placebo and Ustekinumab

Who this might be right for
Psoriasis
MedDerm Associates 15
Testing effectiveness (Phase 2)Study completedNCT00399906
What this trial is testing

BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 99
Large-scale testing (Phase 3)Study completedNCT01550744
What this trial is testing

Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Biotech, Inc. 478
Testing effectiveness (Phase 2)Study completedNCT03463187
What this trial is testing

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 211
Very early researchStudy completedNCT05282771
What this trial is testing

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 402
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation